Tuesday is news day .. There was a mantra , quite a while back.
Tuesday is news day.
I'm not predicting anything based on any facts, that tomorrow being Tuesday will bring news.
However!
We certainly are due some news...
With a list of 3-4 items on the company web site listed as updates eith H2 or this quarter, both at this date the same thing.
in that frame, only 2 business weeks left in this month.
Could be tomorrow?
One thing I have come to accept with Onc, is to expect the unexpected.
Back more than a few years ago, The SP was dismal, the volume near zero.
Out of the blue came the A.N. Deal.
Recall, Sept of last year , again out out if the blue. Onc recieve notice if a $5milkion grant from PanCan , to add an additional cohurt to the Gobblet studies.
and
They selected Onc/ Pelareorep for the phase 3, sponsored Precision promise program.
Those two events combined were great news.
Then again out of the blue. PanCan announced cancellation of any & all new programs going forward.
THAT left Onc in a bind.
Now the predecessor to PanCan, known as CGAR has agreed to carry the ball alongside Onc, into phase 3. Details of that pending.
Some, like to bash mangement at every turn. It was not in any way shape or form the fault of Onc that the Precision promise was cancelled.
What should be acknowledged is praise for getting the deal in the first place. The $5 million grant & ongo8ng additional cohurt still inplace.
As well, now an agreement with CGAR.
Those type of arrangements don't just happen.
Easy to throw stones. " this or thst is late"...look into why.
More importantly, how was the fallout handled?
Back to Tuesday being news day?
Like many Onc retail investors, I check my phone when I wake up, for the oncolyitics biotech update.
Surprisingly , it is when I least expect, that there is news.
We certainly are long over due..and good news would be nice.
Side story, Uber, who daily , many times/ day tout that Onc is a scam & a fraud.
He goes on to proclaim myself & another named Kenny are the most evil people posting.
Ironically, I can not rebut thst, as majority of my posts get rejected by the moderator of that site.
Leaving for the most part random drivel, strong Ad hominem attacks at either mangement.
or evil people like me who make an effort to keep things real.
We have our share on this site.
similar story. Claim to be shareholders, yet attack anything or anyone positive.regarding Onc.
Not a sane relationship.
Regardless of one's opinion, Onc needs a Business development deal to move forward.
Noteable has given ample examples , indicating a. Buyout could be greater than $3 million.
As I said previous, the FDA type C meeting results can set the table for great progress ahead.
Reminder the request was written with inputs from key colaborators.
unnamed?
We know there is a knee deep collaboration with Roche. On- going unfinished business with Pfuzer.
Other less discussed trials with Incyte.
and in back pocket, they still have a deal with A.N.
I'm not certain, but my best read is. a.N. Is waiting for green light from Onc, to start their own phase 3.
Back to the FDA meeting results & what can be included in the phase 3 trial.
Anyhow, a message to Uber.
Since you have such insight & brilliance into Onc being a fraud/ scam, please get on the phone & advise the dozen or so PhDs within CGAR, the lawyers & accountants that did massive DD to allow the $5million grant.
The FDA that has granted fast track approval for both MBc & panc cancer treatments.
and Most importantly Roche. They afterall have been involved with Onc with Gobblet.
Thst being mutiple trials. Including 3 out of 4 that more than exceeded base line, to advance to next phases.
Perhaps Roche, a mutilbillion $$ global pharm company. Been around many decades, needs to hear from you.
Let us know how your phone call goes.